chr1-1512376-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001170535.3(ATAD3A):c.108G>C(p.Gly36=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,220,110 control chromosomes in the GnomAD database, including 33,465 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.34 ( 14097 hom., cov: 30)
Exomes 𝑓: 0.14 ( 19368 hom. )
Consequence
ATAD3A
NM_001170535.3 synonymous
NM_001170535.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0330
Genes affected
ATAD3A (HGNC:25567): (ATPase family AAA domain containing 3A) This gene encodes a ubiquitously expressed mitochondrial membrane protein that contributes to mitochondrial dynamics, nucleoid organization, protein translation, cell growth, and cholesterol metabolism. This gene is a member of the ATPase family AAA-domain containing 3 gene family which, in humans, includes two other paralogs. Naturally occurring mutations in this gene are associated with distinct neurological syndromes including Harel-Yoon syndrome. High-level expression of this gene is associated with poor survival in breast cancer patients. A homozygous knockout of the orthologous gene in mice results in embryonic lethality at day 7.5 due to growth retardation and defective development of the trophoblast lineage. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-1512376-G-C is Benign according to our data. Variant chr1-1512376-G-C is described in ClinVar as [Benign]. Clinvar id is 2688185.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.033 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.735 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATAD3A | NM_001170535.3 | c.108G>C | p.Gly36= | synonymous_variant | 1/16 | ENST00000378756.8 | NP_001164006.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATAD3A | ENST00000378756.8 | c.108G>C | p.Gly36= | synonymous_variant | 1/16 | 1 | NM_001170535.3 | ENSP00000368031 | P1 | |
ATAD3A | ENST00000378755.9 | c.108G>C | p.Gly36= | synonymous_variant | 1/16 | 2 | ENSP00000368030 | |||
ATAD3A | ENST00000672388.1 | n.212G>C | non_coding_transcript_exon_variant | 1/14 | ||||||
ATAD3A | ENST00000339113.9 | upstream_gene_variant | 2 | ENSP00000339421 |
Frequencies
GnomAD3 genomes AF: 0.338 AC: 50828AN: 150364Hom.: 14049 Cov.: 30
GnomAD3 genomes
AF:
AC:
50828
AN:
150364
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.127 AC: 1237AN: 9776Hom.: 119 AF XY: 0.128 AC XY: 633AN XY: 4948
GnomAD3 exomes
AF:
AC:
1237
AN:
9776
Hom.:
AF XY:
AC XY:
633
AN XY:
4948
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.138 AC: 147271AN: 1069642Hom.: 19368 Cov.: 31 AF XY: 0.137 AC XY: 69551AN XY: 508642
GnomAD4 exome
AF:
AC:
147271
AN:
1069642
Hom.:
Cov.:
31
AF XY:
AC XY:
69551
AN XY:
508642
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.339 AC: 50934AN: 150468Hom.: 14097 Cov.: 30 AF XY: 0.344 AC XY: 25301AN XY: 73484
GnomAD4 genome
AF:
AC:
50934
AN:
150468
Hom.:
Cov.:
30
AF XY:
AC XY:
25301
AN XY:
73484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 40% of patients studied by a panel of primary immunodeficiencies. Number of patients: 38. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at